Some studies have shown that treatment with angiotensin converting enzyme inhibitors or angiotensin receptor blockers cannot significantly improve the clinical outcome or prognosis of COVID-19 patients.[26] The present study shows that in patients aged ≥75 years, the control of chronic lung disease may be more meaningful for improving disease prognosis. Here, ACE is linked to COVID-19.